A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users

American Journal of Clinical Nutrition

Volumn 85, Issue 4, 2007, Pages 1098-1102

  Xu, Xinran ^a   Gammon, Marilie D ^b   Wetmur, James G ^a   Rao, Manlong ^a   Gaudet, Mia M ^b   Teitelbaum, Susan L ^a   Britton, Julie A ^a   Neugut, Alfred I ^c   Santella, Regina M ^c   Chen, Jia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Breast cancer; DHFR; Diet; Dihydrofolate reductase; Epidemiology; Folate; Multivitamins; One carbon metabolism; Prospective study

Indexed keywords

DIHYDROFOLATE REDUCTASE; MESSENGER RNA; MULTIVITAMIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL ASSESSMENT; POLYMERASE CHAIN REACTION;

EID: 34147122502     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.4.1098     Document Type: Article

References (27)

1. Picciano MF, Stokstad ELR, Gregory JF. Folic acid metabolism in health and disease. New York, NY: Wiley-Liss, 1990.
2. Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of folate intake and the risk of breast cancer. JAMA 1999;281:1632-7.
3. Seyoum E, Selhub J. Properties of food folates determined by stability and susceptibility to intestinal pteroylpolyglutamate hydrolase action. J Nutr 1998;128:1956-60.
4. Sellers TA, Kushi LH, Cerhan JR, et al. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology 2001;12:420-8.
5. Feigelson HS, Jonas CR, Robertson AS, McCullough ML, Thun MJ, Calle EE. Alcohol, folate, methionine, and risk of incident breast cancer in the American Cancer Society Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2003;12:161-4.
6. Baglietto L, English DR, Gertig DM, Hopper JL, Giles GG. Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study. BMJ 2005;331:807-10.
7. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 2006;83:895-904.
8. Machlin LJ. Handbook of vitamins. 2nd ed, revised and expanded. New York, NY: M. Dekker, 1991.
9. Combs GF. The vitamins: fundamental aspects in nutrition and health. San Diego, CA: Academic Press, 1992.
10. Johnson WG, Stenroos ES, Spychala JR, Chatkupt S, Ming SX, Buyske S. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet A 2004;124:339-45.
11. Farnham PJ, Means AL. Sequences downstream of the transcription initiation site modulate the activity of the murine dihydrofolate reductase promoter. Mol Cell Biol 1990;10:1390-8.
12. Gammon MD, Neugut AI, Santella RM, et al. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 2002;74:235-54.
13. Gammon MD, Santella RM, Neugut AI, et al. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev 2002;11:677-85.
14. Terry MB, Gammon MD, Zhang FF, et al. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004;13:2053-8.
15. Potischman N, Swanson CA, Coates RJ, et al. Intake of food groups and associated micronutrients in relation to risk of early-stage breast cancer. Int J Cancer 1999;82:315-21.
16. Gaudet MM, Britton JA, Kabat GC, et al. Fruits, vegetables, and micronutrients in relation to breast cancer modified by menopause and hormone receptor status. Cancer Epidemiol Biomarkers Prev 2004;13:1485-94.
17. Cox DG, Canzian F. Genotype transposer: automated genotype manipulation for linkage disequilibrium analysis. Bioinformatics 2001;17:738-9.
18. Rothman KJ. Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1998.
19. Hosmer, David W, Lemeshow S. Applied logistic regression. New York, NY: Wiley, 1989.
20. Khoury MJ, James LM. Population and familial relative risks of disease associated with environmental factors in the presence of gene-environment interaction. Am J Epidemiol 1993;137:1241-50.
21. Lundberg M, Fredlund P, Hallqvist J, Diderichsen F. A SAS program calculating three measures of interaction with confidence intervals. Epidemiology 1996;7:655-6.
22. Narayan A, Ji W, Zhang XY, et al. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 1998;77:833-8.
23. Guerin SL, Leclerc S, Verreault H, Labrie F, Luu-The V. Overlapping cis-acting elements located in the first intron of the gene for type I 3 beta-hydroxysteroid dehydrogenase modulate its transcriptional activity. Mol Endocrinol 1995;9:1583-97.
24. Clark IM, Rowan AD, Edwards DR, et al. Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem J 1997;324:611-7.
25. Johnson WG, Scholl TO, Spychala JR, Buyske S, Stenroos ES, Chen X. Common dihydrofolate reductase 19-base pair deletion allele: a novel risk factor for preterm delivery. Am J Clin Nutr 2005;81:664-8.
26. Bertino JR, Donohue DR, Gabrio BW, et al. Increased level of dihydrofolic reductase in leucocytes of patients treated with amethopterin. Nature 1962;193:140-2.
27. Domin BA, Grill SP, Bastow KF, Cheng YC. Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells. Mol Pharmacol 1982;21:478-82.